NCT07838168

Brief Summary

PALONCOPED is a multicentre, interregional, observational and qualitative study aiming to better understand the early integration of palliative care in children with cancer. This study compares the practices, representations and temporalities of integration according to the type of cancer, in particular between hematological malignancies and solid tumors. The study seeks to identify the obstacles and levers encountered by professionals in pediatric onco-haematology and pediatric palliative care resource teams. It will be conducted in the hospitals of Nantes, Angers and Tours, based on about 45 semi-structured individual interviews with healthcare professionals. The data will be analyzed according to a reflexive thematic analysis, supplemented if relevant by a lexical analysis. The project aims to identify ways to improve for organizational and relational improvement, to strengthen collaboration between teams, and to promote earlier, coordinated care pathways adapted to children and their families.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
6mo left

Started Nov 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 24, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

September 24, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

September 18, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

pediatric CancerPalliative CareQualitative study

Outcome Measures

Primary Outcomes (1)

  • Identify the barriers and levers for the early integration of palliative care into pediatric oncology-hematology care, depending on the type of pathology (malignant blood diseases versus so-lide tumors)

    Inclusion (Day 0)

Study Arms (1)

PALONCOPED Study population

We will focus on healthcare professionals working in pediatric onco-haematology services and within the Pediatric Palliative Support Care Teams.

Other: PALONCOPED semi-structured interview

Interventions

Only one semi-structured interview will be conducted per participant. It is estimated that the average duration of interviews is 45 minutes (given for information purposes to allow participants to anticipate the time needed for this interview). Individual interviews will be conducted by 1 researcher in Psychology. The researcher is trained in qualitative medicine and semi-structured interviews. He has extensive experience in this field.

PALONCOPED Study population

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

We will focus on health professionals working in pediatric onco-hematology services and within the Pediatric Palliative Support Care Team. Participation in the study will be offered to professionals from targeted services by the research team directly in the services via both information by email, a poster in the break rooms and a project presentation meeting.

You may qualify if:

  • Healthcare professional (doctor with a thesis that has validated his DES, qualified nurse or puériculturist, qualified childcare assistant or nursing assistant, qualified psychologist, qualified physiotherapist/occupational therapist) practicing in pediatric onco-hematology or within the Pediatric Palliative Support Care Team of three university hospital centers: Nantes, Angers, and Tours., with regular exercise for at least 3 months.
  • Having been involved in supporting a child in a palliative situation in the last 9 months.
  • Agreement of professionals to participate in the study, to record and transcribe interviews.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Estelle THEBAUD

    Nantes UH

    PRINCIPAL INVESTIGATOR
  • Adrien EVIN

    Nantes UH

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sponsor department

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2026

First Posted

September 24, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

September 24, 2026

Record last verified: 2026-09